New Delhi, India | August 28, 2025 With the recent launch of GLP1 medications like Ozempic (Wegovy) and Mounjaro in India, it is more important than ever for people to receive the right guidance and access to safe and evidence-based care. At a time when confusion is high and unregulated options are widespread, Indians deserve clarity and confidence in managing their health. This belief drives Earlyfit, a health tech startup, that is reimagining how India addresses obesity and related conditions such as diabetes, PCOS and obstructive sleep apnea.
Earlyfit is now running India’s first doctor-led GLP1 weight loss program that helps Indians lose up to 20% of their weight. It combines supervised access to medications like semaglutide and tirzepatide with structured follow-up, regular lab testing, personalized nutrition coaching, exercise support and app-based tracking to help people lose weight safely and sustainably.
The program has been designed by Dr. Saptarshi Bhattacharya, Senior Consultant Endocrinologist at Indraprastha Apollo Hospitals and Chief Medical Advisor at Earlyfit, along with Dr. Ankita Aneja, an experienced endocrinologist who has worked at Safdarjung Hospital, Ganga Ram Hospital and RML Hospital, and Dr. Savita Jain, an endocrinologist trained at Indraprastha Apollo Hospitals Delhi, DMC Ludhiana and Mohan Dai Oswal Hospital.
Right combination of efficacy, safety and sustainability
The program includes:
Holistic care with regular medical consults with endocrinologists - doctors super-specialized (DM/DrNB) in diabetes, obesity and hormonal diseases
One-on-one nutrition and lifestyle coaching to keep one accountable
At-home diagnostics (assessing 35 biomarkers), in partnership with Pharmeasy Labs and Healthians
Progress tracking via the EarlyFit app - Meal logging, Apple/Google watch integration and Smart scale shipped to customers
Prescription-based GLP-1 medications, in partnership with Medkart
Comprehensive side effect management support
Fully virtual care for convenience and access to all
The EarlyFit program prioritizes effectiveness and safety . EarlyFit integrates structured lifestyle changes, including a protein-rich nutrition plan and physical activity which not only support fat loss while preserving muscle mass but also help sustain weight loss even after discontinuing the GLP-1 medication.
India’s growing need for medical weight loss
Over 130 million Indians are currently overweight or obese, according to recent NFHS and ICMR data. Urban as well as rural India is also seeing a sharp rise in hormonal and metabolic disorders, such as PCOS, diabetes, fatty liver disease, cholesterol problems and heart attacks. Yet, access to structured, medically guided weight loss programs remains limited, leaving many without the right support or information.
About Earlyfit Founded in 2025, Earlyfit is a metabolic health platform offering doctor-prescribed GLP-1 therapy combined with diagnostics, coaching, and smart tracking tools. The platform is designed to treat obesity in a safe, effective and sustainable manner. Led by endocrinologists, nutritionists, and coaches, Earlyfit is currently available across India and expanding rapidly.
